UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs

Medical mycology (Oxford), 2021-09, Vol.59 (9), p.855-863

2021

Volltextzugriff (PDF)

Observed isavuconazole exposure: 5-year experience of azole TDM from a Spanish reference laboratory

Medical mycology (Oxford), 2023-08, Vol.61 (8)

2023

Volltextzugriff (PDF)

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?

Medical mycology (Oxford), 2021-12, Vol.60 (1)

2021

Volltextzugriff (PDF)

Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients

Medical mycology (Oxford), 2010-11, Vol.48 (O1), p.S52-S59

2010

Volltextzugriff (PDF)

Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland

Medical mycology (Oxford), 2023-11, Vol.61 (11)

2023

Volltextzugriff (PDF)

Isolation of azole-resistant Aspergillus spp. from food products

Medical mycology (Oxford), 2024-03, Vol.62 (4)

2024

Volltextzugriff (PDF)

Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance

Medical mycology (Oxford), 2016-08, Vol.54 (6), p.616-627

2016

Volltextzugriff (PDF)

Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values

Medical mycology (Oxford), 2015-09, Vol.53 (7), p.743-748

2015

Volltextzugriff (PDF)

Usefulness of guideline recommendations for prognosis in patients with candidemia

Medical mycology (Oxford), 2019-08, Vol.57 (6), p.659-667

2019

Volltextzugriff (PDF)

Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan

Medical mycology (Oxford), 2019-11, Vol.57 (8), p.997-1003

2019

Volltextzugriff (PDF)

Ibrexafungerp: A novel oral glucan synthase inhibitor

Medical mycology (Oxford), 2020-07, Vol.58 (5), p.579-592

2020

Volltextzugriff (PDF)

High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis

Medical mycology (Oxford), 2020-02, Vol.58 (2), p.197-200

2020

Volltextzugriff (PDF)

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection

Medical mycology (Oxford), 2011-04, Vol.49 (S1), p.S90-S95

2011

Volltextzugriff (PDF)

One year later: The effect of changing azole-treated bulbs for organic tulips bulbs in hospital environment on the azole-resistant Aspergillus fumigatus rate

Medical mycology (Oxford), 2021-07, Vol.59 (7), p.741-743

2021

Volltextzugriff (PDF)

Prevalence of azole-resistant Aspergillus fumigatus in the environment of Thailand

Medical mycology (Oxford), 2017-06, Vol.55 (4), p.429-435

2017

Volltextzugriff (PDF)

Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates

Medical mycology (Oxford), 2020-08, Vol.58 (6), p.766-773

2020

Volltextzugriff (PDF)

In vitro interactions between IAP antagonist AT406 and azoles against planktonic cells and biofilms of pathogenic fungi Candida albicans and Exophiala dermatitidis

Medical mycology (Oxford), 2018-11, Vol.56 (8), p.1045-1049

2018

Volltextzugriff (PDF)

COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance

Medical mycology (Oxford), 2024-03, Vol.62 (4)

2024

Volltextzugriff (PDF)

Improving health literacy of antifungal use—Comparison of the readability of antifungal medicines information from Australia, EU, UK, and US of 16 antifungal agents across 5 classes (allylamines, azoles, echinocandins, polyenes, and others)

Medical mycology (Oxford), 2023-09, Vol.61 (9)

2023

Volltextzugriff (PDF)

Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections

Medical mycology (Oxford), 2022-05, Vol.60 (5)

2022

Volltextzugriff (PDF)

Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis

Medical mycology (Oxford), 2019-02, Vol.57 (Supplement_1), p.S76-S84

2019

Volltextzugriff (PDF)

Lonafarnib synergizes with azoles against Aspergillus spp. and Exophiala spp

Medical mycology (Oxford), 2018-06, Vol.56 (4), p.452-457

2018

Volltextzugriff (PDF)

Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice

Medical mycology (Oxford), 2018-08, Vol.56 (6), p.703-710

2018

Volltextzugriff (PDF)

Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France

Medical mycology (Oxford), 2015-08, Vol.53 (6), p.593-596

2015

Volltextzugriff (PDF)

A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana

Medical mycology (Oxford), 2017-08, Vol.55 (6), p.686-689

2017

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Current Content Access

SpracheTschechisch

SpracheNiederländisch

SpracheJapanisch

ThemaChemistry

Zeitschrift / SerieMedical Mycology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(105)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(101)
Science & Technology
(101)
Mycology
(100)
Infectious Diseases
(99)
Veterinary Sciences
(98)
Antifungal Agents - Pharmacology
(56)
Humans
(54)
Azoles - Pharmacology
(50)
Microbial Sensitivity Tests
(43)
Drug Resistance, Fungal
(32)
Aspergillus Fumigatus
(26)
Azoles
(23)
Azole Resistance
(22)
Animals
(18)
Fungal Proteins - Genetics
(16)
Antifungal Agents - Therapeutic Use
(15)
Aspergillus Fumigatus - Drug Effects
(14)
Candida - Drug Effects
(13)
Candida Albicans
(12)
Female
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Journals Complete
(105)
Oxford journals
(105)
Oxford Journals 2020 Medicine
(105)
EZB Electronic Journals Library
(105)
Journals@Ovid Ovid Full Text
(105)
Taylor & Francis Journals
(104)
Wiley Online Library
(82)
MEDLINE
(78)
IngentaConnect Journals
(1)
Ingenta.com
(1)
Taylor & Francis
(0)

6 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs

Observed isavuconazole exposure: 5-year experience of azole TDM from a Spanish reference laboratory

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?

Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients

Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland

Isolation of azole-resistant Aspergillus spp. from food products

Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance

Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values

Usefulness of guideline recommendations for prognosis in patients with candidemia

Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan

Ibrexafungerp: A novel oral glucan synthase inhibitor

High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection

One year later: The effect of changing azole-treated bulbs for organic tulips bulbs in hospital environment on the azole-resistant Aspergillus fumigatus rate

Prevalence of azole-resistant Aspergillus fumigatus in the environment of Thailand

Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates

In vitro interactions between IAP antagonist AT406 and azoles against planktonic cells and biofilms of pathogenic fungi Candida albicans and Exophiala dermatitidis

COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance

Improving health literacy of antifungal use—Comparison of the readability of antifungal medicines information from Australia, EU, UK, and US of 16 antifungal agents across 5 classes (allylamines, azoles, echinocandins, polyenes, and others)

Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections

Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis

Lonafarnib synergizes with azoles against Aspergillus spp. and Exophiala spp

Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice

Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France

A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana

Aktive Filter

Suchergebnisse filtern